SmallCap
CompaniesMapStatistics

(주)엑셀세라퓨틱스

Venture Certified
Data Quality: 95/10

Basic Information


Unlisted

Company Name(주)엑셀세라퓨틱스
English NameXcell Therapeutics Inc.
Business Reg. No.5348600230
CEO이의일
Address서울특별시 강남구 영동대로 333 동원빌딩 6층
Industry기초 의약 물질 제조업
Industry Code21100
EstablishedContact
Phone02-863-1331
Websitewww.xcell.media
Regular Employees63persons
Corp. Reg. No.1101115836767

Investment Metrics


Market Cap
-
Op. Margin
-480.91%
ROE
-102.69%
Debt Ratio
83.75%

Certification Status


Venture Certified

Cert. History
연구개발유형2016-06-16 ~ 2018-06-15201601072942016-06-16
연구개발유형2018-06-16 ~ 2020-06-15201801074262016-06-16
벤처투자유형2020-06-16 ~ 2022-06-15202003007372016-06-16
벤처투자유형2022-06-16 ~ 2025-06-15202206150100242016-06-16
벤처투자유형2025-06-16 ~ 2028-06-15202506180100032016-06-16

Financial Statements


3-Year Financial Data

Revenue CAGR +37.7%

Item202420232022
Revenue

19B

11B

10B

Operating Profit

-93B

-87B

-83B

Net Profit

-95B

-92B

-83B

Total Assets

170B

106B

156B

Total Liabilities

78B

81B

70B

Total Equity

93B

25B

86B

Risk Indicators


2 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
19B

80.4%

vs. 3-Year Avg.: 11B
Operating Profit
-93B

9.7%

vs. 3-Year Avg.: -85B
Op. Margin
-480.9%

39.3%

vs. 3-Year Avg.: -792.2%
Debt Ratio
83.8%

58.7%

vs. 3-Year Avg.: 202.8%
ROE
-102.7%

56.1%

vs. 3-Year Avg.: -233.8%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
이의일대표이사대표

Employment Status


NPS Subscribers

63persons

CEO이의일
Est. Avg. Annual Salary

5,24010K

(43710K/mo)
Based on NPS rate 9.5%
Hired (12 mo)

+0persons

Left (12 mo)

-3persons

Net Change (12 mo)

-3persons

NPS Join Date

2015-09-01

Monthly Employee Trend
Hired
Left

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


2 Additional Data Sources

{
  "address": "서울특별시 강남구",
  "ceo_name": "이의일",
  "certificate": [
    {
      "cert_number": "20160107294",
      "changes": "",
      "disclosure_date": "2016-06-16",
      "first_cert_date": "2016-06-16",
      "no": "1",
      "type": "연구개발유형",
      "valid_period": "2016-06-16 ~ 2018-06-15"
    },
    {
      "cert_number": "20180107426",
      "changes": "",
      "disclosure_date": "2018-06-18",
      "first_cert_date": "2016-06-16",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2018-06-16 ~ 2020-06-15"
    },
    {
      "cert_number": "20200300737",
      "changes": "",
      "disclosure_date": "2020-07-02",
      "first_cert_date": "2016-06-16",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2020-06-16 ~ 2022-06-15"
    },
    {
      "cert_number": "20220615010024",
      "changes": "",
      "disclosure_date": "2022-06-15",
      "first_cert_date": "2016-06-16",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2022-06-16 ~ 2025-06-15"
    },
    {
      "cert_number": "20250618010003",
      "changes": "",
      "disclosure_date": "2025-06-18",
      "first_cert_date": "2016-06-16",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2025-06-16 ~ 2028-06-15"
    }
  ],
  "company_name": "㈜엑셀세라퓨틱스",
  "financials": {
    "2022": {
      "capital_stock": 4379707000,
      "cost_of_sales": 2805124000,
      "current_assets": 7160440000,
      "current_liabilities": 5182437000,
      "gross_profit": -1785090000,
      "net_income": -8331061000,
      "net_income_bs": -8331061000,
      "non_current_assets": 8408605000,
      "non_current_liabilities": 1826930000,
      "non_operating_expenses": 212515000,
      "non_operating_income": 172900000,
      "operating_profit": -8291446000,
      "revenue": 1020035000,
      "sga_expenses": 6506357000,
      "total_assets": 15569046000,
      "total_equity": 8559678000,
      "total_liabilities": 7009368000
    },
    "2023": {
      "capital_stock": 4581836000,
      "cost_of_sales": 2988502000,
      "current_assets": 4392056000,
      "current_liabilities": 5437789000,
      "gross_profit": -1864603000,
      "net_income": -9243547000,
      "net_income_bs": -9243547000,
      "non_current_assets": 6184597000,
      "non_current_liabilities": 2642207000,
      "non_operating_expenses": 701713000,
      "non_operating_income": 130327000,
      "operating_profit": -8672161000,
      "revenue": 1123898000,
      "sga_expenses": 6807558000,
      "total_assets": 10576653000,
      "total_equity": 2496658000,
      "total_liabilities": 8079996000
    },
    "2024": {
      "capital_stock": 5459231000,
      "cost_of_sales": 3342159000,
      "current_assets": 10506930000,
      "current_liabilities": 4897039000,
      "gross_profit": -1407815000,
      "net_income": -9513101000,
      "net_income_bs": -9513101000,
      "non_current_assets": 6516494000,
      "non_current_liabilities": 2862099000,
      "non_operating_expenses": 492888000,
      "non_operating_income": 282283000,
      "operating_profit": -9302496000,
      "revenue": 1934344000,
      "sga_expenses": 7894681000,
      "total_assets": 17023424000,
      "total_equity": 9264286000,
      "total_liabilities": 7759138000
    }
  },
  "industry": "기초 의약 물질 제조업",
  "investment": [
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2021-03-18"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2021-03-18"
    },
    {
      "amount": "225,000,000",
      "changes": "225,000,000",
      "date": "2021-03-17"
    },
    {
      "amount": "675,000,000",
      "changes": "675,000,000",
      "date": "2021-03-17"
    },
    {
      "amount": "500,000,000",
      "changes": "500,000,000",
      "date": "2021-03-05"
    },
    {
      "amount": "6,000,000,000",
      "changes": "6,000,000,000",
      "date": "2020-12-21"
    },
    {
      "amount": "510,000,000",
      "changes": "510,000,000",
      "date": "2019-09-18"
    },
    {
      "amount": "2,807,000,000",
      "changes": "2,807,000,000",
      "date": "2019-08-01"
    },
    {
      "amount": "999,997,000",
      "changes": "999,997,000",
      "date": "2019-07-31"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2019-07-31"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2019-07-03"
    },
    {
      "amount": "750,021,636",
      "changes": "750,021,636",
      "date": "2019-07-03"
    },
    {
      "amount": "86,000,000",
      "changes": "86,000,000",
      "date": "2019-01-04"
    },
    {
      "amount": "448,000,000",
      "changes": "448,000,000",
      "date": "2018-12-17"
    },
    {
      "amount": "565,000,000",
      "changes": "565,000,000",
      "date": "2018-10-11"
    }
  ],
  "phone": "02-863-****",
  "source": "pg_migration"
}

{
  "address": "서울특별시 강남구 영동대로",
  "brno": "534860****",
  "cappedWarning": false,
  "companyName": "(주)엑셀세라퓨틱스",
  "estimatedAvgAnnualSalary": 52403292,
  "estimatedAvgMonthlySalary": 4366941,
  "fetchedAt": "2026-03-05T18:21:06.972Z",
  "industryCode": "999999",
  "industryName": "BIZ_NO미존재사업장",
  "joinDate": "20150901",
  "last12MonthsHired": 0,
  "last12MonthsLeft": 3,
  "last12MonthsNetChange": -3,
  "leaveDate": null,
  "monthlyPensionAmount": 26136140,
  "monthlyTrend": [
    {
      "lostSubscribers": 3,
      "newSubscribers": 0,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6459621",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 63,
  "turnoverMonths": 1
}

Data Sources


Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersDART
Collected
EmploymentPublic Data
Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
Venture System Detail2026-03-05
Collected
nps2026-03-05
Collected
DART Financial2026-02-26
Collected
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected